Sonnet BioTherapeutics Holdings, Inc.
SONN
$1.37
$0.010.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.00M | 0.00 | -- | -- | 18.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.00M | 0.00 | -- | -- | 18.60K |
| Cost of Revenue | 1.89M | -4.43M | 1.73M | 2.17M | 644.00K |
| Gross Profit | -886.10K | 4.43M | -1.73M | -2.17M | -625.40K |
| SG&A Expenses | 1.96M | 1.97M | 1.80M | 1.70M | 653.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.85M | 3.17M | 3.53M | 3.87M | 1.30M |
| Operating Income | -2.85M | -3.17M | -3.53M | -3.87M | -1.28M |
| Income Before Tax | -3.00M | -3.13M | -3.51M | 365.40K | -1.17M |
| Income Tax Expenses | 158.40K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.16M | -3.13M | -3.51M | 365.40K | -1.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.16M | -3.13M | -3.51M | 365.40K | -1.17M |
| EBIT | -2.85M | -3.17M | -3.53M | -3.87M | -1.28M |
| EBITDA | -2.85M | -3.17M | -3.53M | -3.87M | -1.28M |
| EPS Basic | -1.56 | -3.33 | -5.57 | 0.63 | -2.46 |
| Normalized Basic EPS | -0.93 | -2.08 | -3.48 | 0.40 | -1.54 |
| EPS Diluted | -1.56 | -3.33 | -5.57 | 0.56 | -2.46 |
| Normalized Diluted EPS | -0.93 | -2.08 | -3.48 | 0.37 | -1.54 |
| Average Basic Shares Outstanding | 2.02M | 940.30K | 629.70K | 577.20K | 474.70K |
| Average Diluted Shares Outstanding | 2.02M | 940.30K | 629.70K | 610.70K | 474.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |